Has your experience with tildrakizumab changed the way you define treatment success in psoriasis?
Featuring:
Updated:Oct 16, 2026
DermInsider Session 6: EB Evolved: Addressing Unmet Needs in Pediatric Epidermolysis Bullosa with Novel TherapiesIn this 45-minute DermInsider, expert faculty explore unmet treatment needs in pediatric epidermolysis bullosa (EB) and the evolving treatment landscape. Join faculty as they review the latest efficacy data for novel therapies, share real-world clinical pearls, and discuss practical strategies for integrating new treatment options into individualized care for patients with EB.This activity is supported by an educational grant from Chiesi USA, Inc.
DermInsider consists of regularly scheduled CME sessions on a variety of dermatological diseases, delivered by the top experts in dermatology. Please join us for this week's session:Wednesday, September 23, 20268 PM ET / 5 PM PTSession 5: Modern Management of Vitiligo: Exploring Current and Future Therapies
DermInsider Session 4: Progress Through Precision: Leveraging IL-13 Insights to Personalize Atopic Dermatitis Care: An Online ActivityThis activity is supported by an educational grant from Lilly.
In the first DermInsider - A Virtual Grand Rounds Series session of the year, join leading experts Dr. Bhutani and Dr. Serota for a dynamic deep dive into one of the most exciting frontiers in psoriatic disease management. Dr. Del Rosso moderates this 45-minute activity that explores the rapidly emerging role of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and their potential impact beyond metabolic disease. Don't miss out on this opportunity to catch up on breakthrough insights and emerging evidence on this hot topic!“We have some really interesting data on the horizon that’s going to hopefully help more providers feel confident about using [GLP-1] medications in conjunction with their psoriasis medications that they are used to using.” – Tina Bhutani, MD MASBest of FC25: GLP-1RAs in Psoriasis – Catching Up on The ScienceThis activity is supported by an educational grant from Lilly.